Atara Biotherapeutics, Inc. 10-Q filing
Filed 2026-05-12 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-219482
- Form type
- 10-Q
- CIK
- 0001604464
- Primary document
- https://www.sec.gov/Archives/edgar/data/1604464/000119312526219482/atra-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $516,000 | - | - |
| Operating Income | $-3.4M | - | - |
| Net Income | $-4.1M | - | - |
| Eps Basic | -0.29 | - | - |
| Eps Diluted | -0.29 | - | - |
| Cash And Equivalents | $8.4M | - | - |
| Total Assets | $20.0M | - | - |
| Total Liabilities | $57.3M | - | - |
| Shareholders Equity | $-37.3M | - | - |
| Operating Cash Flow | $-3.1M | - | - |